Heart disease continues to be one of the leading causes of mortality worldwide and in Saudi Arabia. Yet, the future of cardiovascular care is being rewritten — not just through clinical expertise, but through biotechnology, bioengineering, and innovative solutions that transform how we prevent, diagnose, and treat heart conditions.
HeartFusion 2025 is a premier international conference jointly hosted by Johns Hopkins Aramco Healthcare (JHAH) and King Fahd University of Petroleum and Minerals (KFUPM). This unique event will bring together cardiologists, researchers, bioengineers, healthcare innovators, and policymakers to explore the latest advancements addressing one of Saudi Arabia’s most urgent health challenges – cardiovascular disease. Over three dynamic days, from November 6–8, 2025, participants will engage in a rich program that bridges lab discoveries and clinical practice, offering unparalleled opportunities to learn, collaborate, and innovate.
Focused on biotech and bioengineering solutions, the conference highlights emerging technologies such as bioengineered cardiac devices, AI driven decision support, patient-centered remote monitoring systems, and predictive analytics tools.
Hear from internationally recognized keynote speakers, thought leaders, and clinical experts who are advancing cardiovascular care on a global scale.
Connect with a diverse audience of clinicians, researchers, engineers, and industry leaders — fostering partnerships that accelerate the translation of research into real-world impact.
Participate in workshops, live demonstrations, and interactive sessions designed to equip attendees with actionable skills in cutting-edge cardiac technologies.
Present your own work, engage in peer-reviewed abstract sessions, and gain visibility in a forum dedicated to shaping the next era of cardiology.
HeartFusion 2025 centers on six key innovation drivers that are shaping modern cardiovascular care
Advanced bioengineered devices, regenerative therapies, and biomaterials that are redefining cardiac treatment.
AI-powered algorithms, predictive analytics, and real-time biomarker integration for precise, patient-specific care.
Innovations in advanced heart failure management, key aspects of clinical cardiology, vascular disease management, and catheter-based therapy for aortic disease.
Early detection and proactive interventions powered by biotechnology and molecular diagnostics.
Wearables, implantable sensors, and telehealth platforms enabling continuous, personalized care.
Equipping clinicians and allied professionals to adopt new technologies and lead in precision cardiology.
HeartFusion 2025 is designed for
Cardiologists, cardiac surgeons, vascular surgeons, interventional radiologists, primary care physicians, cardiovascular technicians, allied health professionals, and medical students.
Researchers and academic professionals in cardiovascular science and bioengineering
Healthcare innovators and biotech entrepreneurs
Policymakers, hospital administrators, and industry leaders shaping cardiovascular care strategies
Secure your place among the diverse professionals driving the next generation of Cardiovascular Care and Bioengineering Innovation.
